patients with ALS. These workers also reported significantly greater elevation of plasma glutamate in patients after oral administration of monosodium glutamate (MSG). Previously. Patten et al. [2] reported no significant differences between the serum fasting concentration of 12 control subjects (49 f 19 pmol/l) and that of 12 patients (60 k 29 pmol/l). In both studies glutamate was determined by direct automated amino acid analysis. The discrepancies between these reports may have arisen from procedural differences in sample preparation. In the present study glutamate was determined in whole blood, plasma and erythrocytes by the enzymic method of Beutler [3] after deproteinization of the samples with perchloric acid. Glutamine was subsequently determined in all samples after treatment with glutaminase
The subject population for this study was eight healthy control subjects, 10 patients with ALS and five patients with neurological disorders other than ALS (non-ALS).
Blood was withdrawn by venepuncture from the antecubital vein after overnight fasting and at 30, 60 and 90 min after ingestion of MSG (60 mg/kg body weight, dissolved in water).
Aliquots of blood were taken for whole blood analysis and for haematocrit determination. Erythrocytes were sedimented by centrifugation (2000 g at 4°C for I 0 min). Aliquots of plasma and of erythrocytes (resuspended in water) were analysed. All samples were deproteinized by addition of an equal volume of perchloric acid (1 M). The protein was removed by centrifugation. Addition to the supernatant of 0.5 vol. of 1.93 M-K,PO, to pH 8.0 precipitated potassium perchlorate which was removed by filtration under vacuum. Glutamate and glutamine concentrations o f the filtrate were determined.
No significant difference was observed between the glutamate concentrations of whole blood, of plasma nor of erythrocytes from fasting control subjects ( t i = 8). ALS patients ( n = 10) and patients with other (non-ALS) neurological disorders ( n = 5 ) ( Table 1 ) .
All subjects showed similar responses t o oral ingestion of glutamate (Table 1 ) . Glutamate administered to fasting subjects was shown to pass rapidly into the blood where it was carried predominantly in the plasma with some glutamate passing into the erythrocytes. The amino acid was rapidly cleared from the blood; after 90 rnin the total blood glutamate and its distribution between the plasma and erythrocyte were restored to the fasting values.
PI.
Abbreviations used: ALS. amyotrophic lateral sclerosis; MSG, monosodium glutamate. 
